Highly variable penetrance in subjects affected with cavernous cerebral angiomas (CCM) carrying novel CCM1 and CCM2 mutations
- 17 April 2007
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 144B (5) , 691-695
Abstract
Cavernous vascular malformations may affect brain and out‐of‐brain tissues. In most cases, cerebral cavernous malformations (CCMs) involve the brain alone, and are rarely associated with skin hemangiomas, spinal cord, retinal, hepatic or vertebral lesions. CCMs can cause seizures, intracranial and spinal haemorrhages, focal neurological deficits, and migraine‐like headaches. After collecting CCM families of Italian origin and investigating the genetic basis of the disorder we disclosed two novel molecular variations in the KRIT1 and MGC4607 genes. We found a novel CCM1 gene mutation (Q66X) in a family with apparently asymptomatic old‐aged mutation carriers and patients who either had skin angiomas alone or the full association of cerebral, spinal, and skin lesions. In this family we report the highest variability in mutation penetrance so far described, including the presence of CCM in one subject since birth (surgery at 19 months of age), a condition to our knowledge so far unreported. In a CCM2 affected family, we also report a novel causative mutation, (54_55delAC) in exon 2 of the MGC4607 gene, that produces a truncated protein containing only 22 amino acids. These data describe novel CCM mutations associated with a particularly high variability of the penetrance causing, in some cases, reduced expression of clinical symptoms and sporadic cases with apparent negative family history. Hence they emphasize the importance of DNA‐based diagnostics and genetic counseling to identify unaffected mutation carriers subjects, even at advanced age.Keywords
This publication has 12 references indexed in Scilit:
- Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locusHuman Mutation, 2005
- Genetics of cerebral cavernous malformationsCurrent Neurology and Neuroscience Reports, 2005
- Clinical features of cerebral cavernous malformations patients with KRIT1 mutationsAnnals of Neurology, 2003
- Mutations in a Gene Encoding a Novel Protein Containing a Phosphotyrosine-Binding Domain Cause Type 2 Cerebral Cavernous MalformationsThe American Journal of Human Genetics, 2003
- Identification of a novel KRIT1 mutation in an Italian family with cerebral cavernous malformation by the protein truncation testJournal of the Neurological Sciences, 2003
- Vascular morphogenesis: tales of two syndromesHuman Molecular Genetics, 2003
- Hereditary cerebral cavernous angiomas: clinical and genetic features in 57 French familiesThe Lancet, 1998
- Linkage of the locus for cerebral cavernous hemangiomas to human chromosome 7q in four families of Mexican-American descentNeurology, 1997
- A Founder Mutation as a Cause of Cerebral Cavernous Malformation in Hispanic AmericansNew England Journal of Medicine, 1996
- Cerebral Cavernous MalformationsNew England Journal of Medicine, 1988